PALO ALTO, Calif., April 9, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced a new version of its Velocity™
Rapidsphere runs on the Velocity software platform, which aggregates unstructured treatment and imaging data from diverse systems to show a comprehensive view of a patient's diagnostic imaging and treatment history. Rapidsphere is an integrated image-guided dosimetry system for calculating the absorbed dose using post-treatment emission tomography imaging from Y90 SIRT. Varian will be hosting a webinar on April 13 at 3pm EDT to discuss more details about Rapidsphere. To register to view the webinar, visit www.varian.com/rapidsphere/webinar.
"At Varian, we are focused on providing clinicians with powerful and comprehensive solutions that enable them to provide personalized cancer therapy for patients," said Kolleen Kennedy, president of Varian's Oncology Systems business. "Patient-specific 3D imaging and dosimetry for targeted cancer therapy delivery is important for predicting the tumor's response to therapy. The Rapidsphere module is a significant advancement for interventional radiologists performing Y90 SIRT."
Velocity 4.0 incorporates several new features or improved functionalities. Additional new features in Velocity 4.0 include:
For more information on Velocity and Rapidsphere, visit www.varian.com/rapidsphere.
About Varian Varian is a leader in developing and delivering cancer care solutions, and is focused on creating a world without fear of cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,500 people around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.
Press ContactMark PlungyDirector, Public Relations+1 (650) 424-5630 firstname.lastname@example.org
Investor Relations ContactJ. Michael BruffSenior Vice President, Investor Relations+1 (650) 424-5163 email@example.com
View original content:http://www.prnewswire.com/news-releases/varian-launches-velocity-40-cancer-imaging-software-with-selective-internal-radiation-therapy-dosimetry-analysis-300625867.html
Subscribe to our Free Newsletters!